Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05792852 · ClinicalTrials.gov registry record · NA
Improving the Health and Social Participation of People With Disabilities From Underrepresented Groups Post COVID
A NA study of Disabilities Multiple, sponsored by University of Illinois at Chicago.
- Recruiting
- Registry status
- NA
- Development phase
- 21
- Enrollment target
- 1
- Study location
NCT05792852 is a NA study of Disabilities Multiple that is actively recruiting participants, run by University of Illinois at Chicago. The registered enrollment target is 21 participants. The trial reports 1 study location across 1 state.
The verdict
NCT05792852, a NA study of Disabilities Multiple, is actively recruiting participants, sponsored by University of Illinois at Chicago.
- RECRUITING
- Registry status
- NA
- Development phase
- 21 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a single-arm community-based feasibility study examining recruitment, retention, adherence, and satisfaction with ENGAGE, a community-based intervention designed to address pandemic-related social isolation among people with disabilities. We will also examine preliminary, within-group effects on social participation. The findings of this study will inform a larger trial to examine intervention efficacy.
Conditions Studied
Interventions
- BEHAVIORAL ENGAGE
Study Locations (1)
Illinois
- University of Illinois Chicago - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2023-04-01 |
| Est. Completion | 2026-01-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05792852
The ClinicalTrials.gov registry entry for NCT05792852 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 21 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Illinois at Chicago, which has 430 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Disabilities Multiple appearing as the primary indexed condition, and to 1 intervention - of which ENGAGE is the first listed.
NCT05792852 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.
Frequently Asked Questions
What is clinical trial NCT05792852 about?
NCT05792852 is a clinical study titled "Improving the Health and Social Participation of People With Disabilities From Underrepresented Groups Post COVID". This is a single-arm community-based feasibility study examining recruitment, retention, adherence, and satisfaction with ENGAGE, a community-based intervention designed to address pandemic-related social isolation among people with disabilities. We will also examine preliminary, within-group effect...
What is the current status of trial NCT05792852?
This trial is currently recruiting. It is a NA study. The enrollment target is 21 participants. The study started on 2023-04-01. Estimated completion is 2026-01-31.
What conditions does trial NCT05792852 study?
This clinical trial studies the following conditions: Disabilities Multiple.
What interventions are being tested in trial NCT05792852?
The interventions under investigation include: ENGAGE (BEHAVIORAL).
Who is sponsoring clinical trial NCT05792852?
This trial is sponsored by University of Illinois at Chicago, which has 430 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05792852 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Disabilities Multiple
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.